Company intelligence / Profile preview

Esensa

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Esensa is a Serbian manufacturer specializing in dietary supplements, medical devices, cosmetics, and biocidal products. The company operates both its own brands and as a contract manufacturer for global clients. It holds permits for manufacturing medical devices since 2009 and distributing pharmaceuticals since 2011. Its portfolio is commercialized across more than 40 countries.

Therapeutic areas: GastroenterologyDermatologyImmunology
Modalities: Small moleculeBiologicMedical device
Industry: Consumable Medical Devices

Drug pipeline

2 assets

simethicone

Commercial

Indications: Gas relief

1 more asset in the full pipeline.

Request access →

Partnerships

Not specifically listed; acts as contract manufacturer/service provider to various international companies

Beyond the preview

Go deeper on Esensa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Esensa.

Explore the full profile